Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.
Citation: Journal of Thrombosis & Thrombolysis. 43(2):166-171, 2017 FebPMID: 27696084Institution: MedStar Washington Hospital CenterDepartment: Hematology/OncologyForm of publication: Journal ArticleMedline article type(s): Journal Article | Validation StudiesSubject headings: *Neoplasms/co [Complications] | *Rivaroxaban/tu [Therapeutic Use] | *Venous Thromboembolism/dt [Drug Therapy] | Anticoagulants/tu [Therapeutic Use] | Cohort Studies | Female | Hemorrhage/ci [Chemically Induced] | Humans | Male | Middle Aged | Neoplasms/dt [Drug Therapy] | Prospective Studies | Recurrence | Rivaroxaban/st [Standards] | Treatment Outcome | Venous Thromboembolism/et [Etiology]Year: 2017ISSN:- 0929-5305
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 27696084 | Available | 27696084 |
English